New Recruiting Trial: 18F-mFBG Cardiac Uptake With Lewy Body Dementia

WHY IT MATTERS

This trial is now actively recruiting patients with Lewy body dementia — if you have this diagnosis, you may be eligible to participate in a study that could help develop better diagnostic tools for your condition.

Researchers are testing a new imaging scan called 18F-mFBG that can take pictures of the heart in people with Lewy body dementia, a brain disease that causes movement problems and thinking difficulties. This Phase 2 trial is now accepting patients and aims to see if this special scan can help doctors better understand and diagnose the disease. The scan uses a safe radioactive tracer that shows how well the heart's nerve endings are working.

NCT ID: NCT07176286 Title: 18F-mFBG Cardiac Uptake With Lewy Body Dementia Status: RECRUITING Phase: PHASE2 Sponsor: Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) Start date: 2026-04-15 URL: https://clinicaltrials.gov/study/NCT07176286 Source: UniteRare clinical trials database

YOU CAN ACT ON THIS

If you have been diagnosed with Lewy body dementia, visit clinicaltrials.gov/study/NCT07176286 to check eligibility requirements and contact the research team about enrolling.